These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3265458)

  • 1. [Disorders of color perception in subtoxic and toxic digoxin and serum digoxin concentrations].
    Duncker G; Horst HA; Kolenda KD; Schenck F
    Klin Monbl Augenheilkd; 1988 Dec; 193(6):622-6. PubMed ID: 3265458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incidence and extent of digitalis-induced disorders of color vision. A comparative study of subtoxic and toxic digoxin and digitoxin serum concentrations].
    Horst HA; Kolenda KD; Duncker G; Schenck F; Löffler H
    Med Klin (Munich); 1988 Sep; 83(17):541-7. PubMed ID: 3262815
    [No Abstract]   [Full Text] [Related]  

  • 3. [Color perception disorders in therapeutic glycoside serum concentrations].
    Duncker G; Horst H; Kolenda KD; Schenck F
    Fortschr Med; 1983 Nov; 101(43):1970-3. PubMed ID: 6654298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of colour vision measurement in the diagnosis of digoxin toxicity.
    Aronson JK; Ford AR
    Q J Med; 1980; 49(195):273-82. PubMed ID: 6970370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Color vision testing to assist in diagnosis of digoxin toxicity.
    LeSage J
    Nurs Res; 1984; 33(6):346-51. PubMed ID: 6333672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Color vision deficiencies: a common sign of intoxication in chronically digoxin-treated patients.
    Rietbrock N; Alken RG
    J Cardiovasc Pharmacol; 1980; 2(1):93-9. PubMed ID: 6154209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in color discrimination between three cardioactive glycosides.
    Haustein KO; Schmidt C
    Int J Clin Pharmacol Ther Toxicol; 1988 Oct; 26(10):517-20. PubMed ID: 3235219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Digitalis-induced color vision deficiencies and therapeutic glycoside concentrations].
    Duncker G; Kolenda KD; Schenk F
    Fortschr Ophthalmol; 1983; 79(6):503-5. PubMed ID: 6603402
    [No Abstract]   [Full Text] [Related]  

  • 9. Introducing a new computer-based test for the clinical evaluation of color discrimination.
    Melamud A; Simpson E; Traboulsi EI
    Am J Ophthalmol; 2006 Dec; 142(6):953-60. PubMed ID: 17157581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farnsworth-Munsell 100-hue test for patients with diabetes mellitus.
    Utku D; Atmaca LS
    Ann Ophthalmol; 1992 Jun; 24(6):205-8. PubMed ID: 1444079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of age-related lens yellowing on Farnsworth-Munsell 100 hue error score.
    Beirne RO; McIlreavy L; Zlatkova MB
    Ophthalmic Physiol Opt; 2008 Sep; 28(5):448-56. PubMed ID: 18761482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in color vision impairment caused by digoxin, digitoxin, or pengitoxin.
    Haustein KO; Oltmanns G; Rietbrock N; Alken RG
    J Cardiovasc Pharmacol; 1982; 4(4):536-41. PubMed ID: 6181326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ocular side effects of digitalis (author's transl)].
    Duncker G
    Klin Monbl Augenheilkd; 1981 May; 178(5):397-8. PubMed ID: 6973045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium status and digoxin toxicity.
    Young IS; Goh EM; McKillop UH; Stanford CF; Nicholls DP; Trimble ER
    Br J Clin Pharmacol; 1991 Dec; 32(6):717-21. PubMed ID: 1768564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An averaging method for the interpretation of the Farnsworth-Munsell 100-Hue Test--II. Colour vision defects acquired in diabetic retinopathy.
    Birch J; Dain SJ
    Ophthalmic Physiol Opt; 1987; 7(3):281-91. PubMed ID: 3500447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of colour difference vectors in diagnosing congenital colour vision deficiencies with the Farnsworth-Munsell 100-hue test.
    Vingrys AJ; Atchison DA; Bowman KJ
    Ophthalmic Physiol Opt; 1992 Jan; 12(1):38-45. PubMed ID: 1584615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ocular side effects of beta-pyridylcarbinol].
    Wolff-Kormann PG; Kormann BA; Riedel KG; Keller C; Miliczek KD; Zrenner E
    Fortschr Ophthalmol; 1991; 88(6):857-60. PubMed ID: 1794821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Color vision in 42 Congolese patients with tuberculosis receiving ethambutol treatment.
    Kaimbo WK; Bifuko ZA; Longo MB; Dralands L; Missotten L
    Bull Soc Belge Ophtalmol; 2002; (284):57-61. PubMed ID: 12161991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huematic--an automated scorer for the Farnsworth-Munsell 100 hue test.
    Hill AR; Reeves BC; Burgess A
    Eye (Lond); 1988; 2 ( Pt 1)():80-6. PubMed ID: 3261697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An averaging method for the interpretation of the Farnsworth-Munsell 100-Hue Test--I. Congenital colour vision defects.
    Dain SJ; Birch J
    Ophthalmic Physiol Opt; 1987; 7(3):267-80. PubMed ID: 3500446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.